1 / 33

Chemical Dependency

Chemical Dependency. Disease Entities. Alcoholism: A Prototype Disease. Alcohol Dependence can be viewed as a prototype of chemical (substance) use and dependence. E.M. Jellinek, pioneer of the disease model, identified phases of abuse-to-dependence.

lynn
Télécharger la présentation

Chemical Dependency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chemical Dependency Disease Entities

  2. Alcoholism: A Prototype Disease Alcohol Dependence can be viewed as a prototype of chemical (substance) use and dependence. E.M. Jellinek, pioneer of the disease model, identified phases of abuse-to-dependence

  3. Jellinek’s Four Phases • The individual with alcoholism progresses through these phases. • The characteristics of the phases can assist clients, families and health care providers in understanding 1) the loss of control and 2) ethical deterioration characteristic of individuals with chronic chemical dependency (regardless of the chemical of choice). • View chart of these phases at: http://www.in.gov/judiciary/ijlap/docs/jellinek.pdf

  4. Phase I: Pre-alcoholic Phase • Chemical used to relieve stress • Tolerance develops

  5. Phase II: Early Alcoholic Phase • Begins with the first blackout • The chemical is no longer associated with pleasure or relief • The individual requires the chemical • The individual is increasingly secretive; becomes preoccupied with chemical use and maintenance of supply • Individual is increasingly reliant upon the defense mechanisms of denial and rationalization • Use is associated with guilt and shame

  6. Phase III: Middle or Crucial Phase • Individual demonstrates signs and symptoms of Physiological and Psychological dependence • Binge use often occurs • Interactions are characterized by anger and aggression • Family dysfunction • Individual demonstrates impairment in social and occupational functioning

  7. Phase IV: Late or Chronic Phase • The individual is almost always intoxicated • Ethical deterioration is apparent • Impaired reality testing, especially paranoia, is evident • Depression with suicidal ideation is common • Life-threatening physical consequences are evident: • Peripheral neuritis with LE numbness, pain • Alcoholic myopathy • Wernicke-Korsakoff syndrome • Alcoholic cardiopathy

  8. Phase IV: Late or Chronic Phase, cont. • Hepatitis • Cirrhosis (complications include portal hypertension, ascites, esophageal varices and hepatic encephalopathy) • Esophagitis and gastritis (ulcers, hemorrhage) • Pancreatitis • Leukopenia • Thrombocytopenia • Sexual dysfunction

  9. Substance Profiles

  10. ALCOHOL DEPENDENCE: Some Facts • 5-7% of Americans are Alcoholics • Every alcoholic touches lives of 5 people • A leading cause of death: from medical complications, accidents and suicides • Fetal alcohol syndrome most common cause of mental retardation in children • Potentiates other CNS depressants • Alcoholism underreported in women and older adults

  11. Alcohol: Intoxication • Metabolism of alcohol is increased in heavy drinkers • Women more easily intoxicated than men. • Effects: CNS depression and Peripheral vasodilation • Decreased muscle tension, lowered anxiety level, disinhibition, impaired judgment, sedation  Toxic effects: stupor, unconsciousness (including blackouts), coma, death

  12. Alcohol Withdrawal • Usually develops 4-12 hours after cessation or reduction of alcohol use • Rebound phenomenon (CNS irritability) as drug effects wear off: • increased anxiety, tension, psychomotor activity • sweats, tremors, tachycardia, increased temp. and BP • nausea, vomiting, diarrhea

  13. Alcohol Withdrawal, cont’d • Withdrawal seizures may occur 7-48 hours after cessation or reduction • Alcohol withdrawal delirium (also known as Delirium Tremens or DTs) may occur 48-72 hours following cessation or reduction- agitation, terror, hallucinations • Use of validated withdrawal assessment rating scale assists in objective description of withdrawal severity (A Belgian beer is named for this effect)

  14. Validated withdrawal assessment scale: Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar)

  15. Alcohol: Interventions • Seizure precautions; anticonvulsants for DT’s • Suicide assessment and precautions, if necessary • Medications: for withdrawal • Benzodiazepines e.g. chlordiazepoxide (Librium), oxazepam (Serax), diazepam (Valium). Administration may depend on withdrawal rating parameters. • Medications to promote abstinence after detox. • disulfiram (Antabuse) = Aversive Therapy; produces unpleasant or even harmful effects when alcohol is consumed or absorbed in any form (in foods, fluids, cosmetics, medications, etc.). • naltrexone (ReVia) – opiate receptor antagonist-blocks the “high” • acamprosate (Campral) – reduces cravings

  16. SEDATIVES, HYPNOTICS AND ANXIOLYTICS BARBITURATES BENZODIAZEPINES • Are CNS depressants • Commonly prescribed for sleep, anxiety, muscle spasms, etc. • Also used illicitly, including • reducing effects of amphetamine abuse • if other narcotics not available • by sexual predators

  17. Sedative, Hypnotic, or Anxiolytic Abuse and Dependence • Potentiate each other and alcohol • Produce physiological dependence • Produce psychological dependence • Cross-tolerance and cross-dependence between CNS depressants • Withdrawal sx.: anxiety, insomnia, nausea, seizures  Overdose and Fatal effects: respiratory depression, coma, death

  18. Interventions for Sedative W/D • Quiet, calm environment • Monitor vital signs • Taper dose gradually; may take weeks or months • Seizure precautions

  19. INHALANTS: Abuse and Dependence • Generally act as CNS depressants • Dangerous due to inability to control amount inhaled • Use is associated with • CNS damage • Respiratory irritation, distress and depression • GI distress • Mouth ulcers • Renal and hepatic damage  Death from asphyxiation or suffocation

  20. OPIOIDS • OPIUM and HEROIN • MORPHINE • CODEINE • SYNTHETIC MORPHINE DERIVATIVES, e.g: • OXYCODONE (OxyContin) • HYDROMORPHONE ((Dilaudid) • HYDROCODONE (Vicodin) • MEPERIDINE (Demerol)

  21. OPIOID Abuse and Dependence • Activate endorphins, reduce pain and anxiety • Many routes of use: po, subcut., IM, IV, inhaled • IV use is associated with infection, including HIV and Hepatitis, bacterial endocarditis, and abscesses • May be prescribed or illicitly obtained • Heroin--highest abuse and dependence potential • CNS effects, including respiratory depression • GI effects

  22. Opioid Intoxication • Initial euphoria • Followed by apathy, dysphoria, psychomotor agitation or retardation, impaired judgment • Pupillary constriction • Drowsiness (“nodding”), slurred speech • Impaired memory and concentration

  23. Opioid Overdose  Pinpoint pupils  Clammy skin  Respiratory depression  Coma (pupils will dilate secondary to anoxia) • Death rapidly follows coma Narcotic antagonist used to reverse overdose: naloxone (Narcan)

  24. Opioid Withdrawal Symptoms very uncomfortable but rarely dangerous: • Dysphoria, anxiety, cravings • Sweating and chills • Lacrimation, rhinorrhea • GI distress (anorexia, n/v, cramping, diarrhea) • Muscle aches, bone pain • Restlessness • Tremors • Sleep disturbances • Yawning

  25. Treatment for Opioid Withdrawal • Primarily supportive care • Treat symptomatically • Specific pharmacotherapy: • clonidine-for n/v/diarrhea • buprenorphine (Buprenex) –reduces pain and discomfort

  26. Example of clinical assessment tool for opiate withdrawal (COWS)

  27. Opioid Dependence: Interventions Promoting Abstinence • Maintenance Pharmacotherapy to reduce cravings and block the “high” : • naltrexone (Trexan, ReVia) • methadone –requires enrollment in maintenance program (federally controlled supervision)

  28. CNS STIMULANTS: Abuse and Dependence Cocaine Amphetamines: prescribed or illicit Non-amphetamine stimulants Caffeine Nicotine

  29. STIMULANTS: Cocaine Intoxication and Dependence • Cocaine –Blocks dopamine reuptake esp. in nucleus accumbens (pleasure center) • IV or intranasal route; Crack (dilute) form is smoked • Rapid Effects and Rapidly metabolized: • Intense euphoria • Increased mental alertness • Increased motor and cardiac activity • Increased muscle strength • Psychological dependence is even more severe than physical dependence; cravings are intense

  30. Amphetamines: Intoxication and Dependence • Often are prescribed, widely abused • Methamphetamine: Slower metabolic effects, often mixed with cocaine (cheaper) • Routes: IV, intranasal, po, smoked • Immediate intense pleasure, lasting high • “Crash” occurs as drug effects wear off • Intense cravings promote frequent, repetitive use • Neglect of nutrition and dental care

  31. STIMULANTS: Complications • Toxic effects: Hallucinations and paranoid delusions Severe hypertension, cardiac ischemia • Withdrawal: severe agitation, anxiety, depression • Death from cardiac arrhythmias, seizures, suicide, respiratory collapse, stroke Treatment of Overdose: Induce vomiting, diuretics, administer IM antipsychotic for drug-induced psychosis/agitation (There are no medications that can treat stimulant dependence)

  32. Comparison Chart

More Related